Tandem Diabetes Care/$TNDM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Tandem Diabetes Care

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Ticker

$TNDM
Primary listing

Industry

Health Care Equipment & Supplies

Employees

2,650

ISIN

US8753722037

TNDM Metrics

BasicAdvanced
$1.4B
-
-$2.80
1.53
-

What the Analysts think about TNDM

Analyst ratings (Buy, Hold, Sell) for Tandem Diabetes Care stock.

Bulls say / Bears say

Tandem Diabetes Care's recent launch of the t:slim X2 insulin pump with Control-IQ technology has been well-received, potentially driving increased sales and market share. (bloomberg.com)
The company's strategic partnership with Dexcom to integrate continuous glucose monitoring systems enhances product offerings and could lead to higher adoption rates. (reuters.com)
Tandem's expansion into international markets, including recent approvals in Europe and Asia, positions the company for significant revenue growth. (seekingalpha.com)
Increased competition from larger medical device companies entering the insulin pump market could pressure Tandem's market share and pricing power. (bloomberg.com)
Supply chain disruptions have led to delays in product shipments, potentially impacting quarterly revenues and customer satisfaction. (reuters.com)
Regulatory challenges in obtaining approvals for new products in certain international markets may hinder Tandem's expansion plans. (seekingalpha.com)
Data summarised monthly by Lightyear AI. Last updated on 10 Jun 2025.

TNDM Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

TNDM Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $TNDM

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs